Canlyniadau Chwilio - Derfuss, Tobias

Personalized medicine in multiple sclerosis: hope or reality? gan Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis gan Diebold, Martin, Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Lymphocyte recovery after fingolimod discontinuation in patients with MS gan Nagy, Sara, Kuhle, Jens, Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

B Cells and Autoantibodies in Multiple Sclerosis gan Pröbstel, Anne-Katrin, Sanderson, Nicholas S. R., Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy gan Rust, Heiko, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Defining distinct features of anti-MOG antibody associated central nervous system demyelination gan Weber, Martin S., Derfuss, Tobias, Metz, Imke, Brück, Wolfgang

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Relapse rates in patients with multiple sclerosis treated with fingolimod: subgroup analyses of pooled data from three phase 3 trials gan Derfuss, Tobias, Ontaneda, Daniel, Nicholas, Jacqueline, Meng, Xiangyi, Hawker, Kathleen

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation gan Voigt, David, Scheidt, Uta, Derfuss, Tobias, Brück, Wolfgang, Junker, Andreas

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis gan Waschbisch, Anne, Atiya, Monika, Linker, Ralf A., Potapov, Sergej, Schwab, Stefan, Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis gan Havla, Joachim, Warnke, Clemens, Derfuss, Tobias, Kappos, Ludwig, Hartung, Hans-Peter, Hohlfeld, Reinhard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML gan Fischer-Barnicol, Bettina, Oechtering, Johanna, Kuhle, Jens, Lorscheider, Johannes, Kappos, Ludwig, Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Antiapoptotic Activity of the Herpesvirus Saimiri-Encoded Bcl-2 Homolog: Stabilization of Mitochondria and Inhibition of Caspase-3-Like Activity gan Derfuss, Tobias, Fickenscher, Helmut, Kraft, Michael S., Henning, Golo, Lengenfelder, Doris, Fleckenstein, Bernhard, Meinl, Edgar

Cael y testun llawn Cael y testun llawn

Prevalence of HSV‐1 LAT in Human Trigeminal, Geniculate, and Vestibular Ganglia and Its Implication for Cranial Nerve Syndromes gan Theil, Diethilde, Arbusow, Viktor, Derfuss, Tobias, Strupp, Michael, Pfeiffer, Matthias, Mascolo, Andrea, Brandt, Thomas

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Expression of Herpes Simplex Virus 1-Encoded MicroRNAs in Human Trigeminal Ganglia and Their Relation to Local T-Cell Infiltrates gan Held, Kathrin, Junker, Andreas, Dornmair, Klaus, Meinl, Edgar, Sinicina, Inga, Brandt, Thomas, Theil, Diethilde, Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients gan Waschbisch, Anne, Sanderson, Nicholas, Krumbholz, Markus, Vlad, George, Theil, Diethilde, Schwab, Stefan, Mäurer, Mathias, Derfuss, Tobias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment gan Diebold, Martin, Fischer-Barnicol, Bettina, Tsagkas, Charidimos, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias, Décard, Bernhard F.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis gan Lorscheider, Johannes, Benkert, Pascal, Lienert, Carmen, Hänni, Peter, Derfuss, Tobias, Kuhle, Jens, Kappos, Ludwig, Yaldizli, Özgür

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose gan Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf, Mäurer, Mathias, Stangel, Martin, Zipp, Frauke

Cael y testun llawn Cael y testun llawn

Optimizing treatment success in multiple sclerosis gan Ziemssen, Tjalf, Derfuss, Tobias, de Stefano, Nicola, Giovannoni, Gavin, Palavra, Filipe, Tomic, Davorka, Vollmer, Tim, Schippling, Sven

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Aggressive multiple sclerosis (1): Towards a definition of the phenotype gan Iacobaeus, Ellen, Arrambide, Georgina, Amato, Maria Pia, Derfuss, Tobias, Vukusic, Sandra, Hemmer, Bernhard, Tintore, Mar, Brundin, Lou

Cael y testun llawn Cael y testun llawn Cael y testun llawn